Clinical Trials Directory

Trials / Unknown

UnknownNCT03407027

Efficacy of Corticoid Infiltration in Quadratus Lumborum Syndrome

Evaluation of Triamcinolone's Efficacy on the Ultrasound- Guided Infiltration in the Quadratus Lumborum Syndrome: a Double Blind, Randomized, Controlled Study

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
66 (estimated)
Sponsor
Hospital de Braga · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study has the primary goal of evaluating the efficacy of corticoid infiltration in the quadratus lumborum syndrome, aiming to determine if there are benefits with the use of corticosteroids and if they exist, if this improvement comes only from the systemic effects of corticosteroid administration.

Detailed description

This study has the primary goal of evaluating triamcinolone's efficacy on the ultrasound- guided infiltration in the quadratus lumborum syndrome, aiming to determine if there are benefits with the use of corticosteroids and if they exist, if this improvement comes only from the systemic effects of corticosteroid administration. It is an interventional study, double-blinded and randomized, in a sample of patients followed in the Chronic Pain Unit (Hospital of Braga, Portugal), proposed for ultrasound infiltration of the quadratus lumborum muscle. The selection of the patients will take into account the inclusion and exclusion criteria, until reach the required sample size (66 patients). The confirmation of the inclusion criteria will be done by a physiatrist blind to randomization. Different protocols will be randomly applied to patients after obtaining written informed consent. The techniques will be performed by two anesthetists. The data will be obtained through questionnaires filled out on the day of the technique and in the course of 1, 3 and 6 months in chronic pain consultation and by telephone call 72 hours after the procedure. It will be a psychologist, blind to randomization, to fill the questionnaires. Patients will be also evaluated in consultation, at the same time, the course of 1, 3 and 6 months. After the data collection it will be performed a statistical analysis.

Conditions

Interventions

TypeNameDescription
DRUGQuadratus triamcinolone40mg of triamcinolone and 10ml of levobupivacaine 0,25%.
DRUGGluteus triamcinolone40mg of triamcinolone and 10ml of levobupivacaine 0,25%.
DRUGquadratus without triamcinolone.10ml of levobupivacaine 0,25%.

Timeline

Start date
2017-11-01
Primary completion
2019-04-30
Completion
2019-11-01
First posted
2018-01-23
Last updated
2018-01-23

Locations

1 site across 1 country: Portugal

Source: ClinicalTrials.gov record NCT03407027. Inclusion in this directory is not an endorsement.